AI assistant
Sending…
RESMED INC — Director's Dealing 2021
Jul 16, 2021
30071_dirs_2021-07-16_cf3b12b6-8b67-4c8d-9e56-d464af1cc2bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-07-15
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-15 | ResMed Common Stock | M | 8000 | $58.24 | Acquired | 24767 | Direct |
| 2021-07-15 | ResMed Common Stock | S | 8000 | $248.00 | Disposed | 16767 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-15 | ResMed Common Stock Options | $58.24 | M | 8000 | Disposed | 2022-11-19 | ResMed Common Stock (8000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 210407 | Indirect |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29